Waters Corporation (WAT) Price/FCF Ratio: 113.83
Is Waters Corporation’s Price/FCF ratio high or low?
Waters Corporation's Price/FCF ratio of 113.83 is 196% above its 5-year average of 38.40, near the high end of its 5-year range (26.75–119.34).
The Price/FCF ratio for Waters Corporation (WAT) is 113.83. It is above its 12-month average by 183.70% (40.12).
WAT Price/FCF Ratio Chart
WAT Average Price/FCF Ratio Chart
WAT Current vs Average Price/FCF Ratio Chart
WAT Price/FCF Ratio Metrics
PRICE/FCF RATIO
113.83
PRICE/FCF RATIO AVG TTM
40.12
PRICE/FCF RATIO AVG 3Y
39.39
PRICE/FCF RATIO AVG 5Y
38.40
PRICE/FCF RATIO AVG 10Y
33.21
PRICE/FCF RATIO AVG 15Y
29.69
PRICE/FCF RATIO AVG 20Y
27.27
CURRENT VS TTM AVG
+183.70%
CURRENT VS 3Y AVG
+188.97%
CURRENT VS 5Y AVG
+196.46%
CURRENT VS 10Y AVG
+242.75%
CURRENT VS 15Y AVG
+283.42%
CURRENT VS 20Y AVG
+317.42%
WAT Competitors' Price/FCF Ratio
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Waters Corporation (WAT) | — | 113.83 | 40.12 | 39.39 | 38.40 |
| Mettler-Toledo International Inc. (MTD) | $22.85B | 28.92 | 31.25 | 31.11 | 36.01 |
| BioNTech SE (BNTX) | $21.81B | 14.58 | 36.28 | 10.84 | 14.33 |
| Veeva Systems Inc. (VEEV) | $26.73B | 52.43 | 30.62 | 33.98 | 39.46 |
| Biogen Inc. (BIIB) | $29.00B | 11.12 | 11.07 | 18.73 | 18.56 |
| DexCom, Inc. (DXCM) | $29.24B | 20.82 | 36.11 | 64.02 | 176.73 |
| Moderna, Inc. (MRNA) | $18.40B | N/A | 28.07 | 27.23 | 27.23 |
| IQVIA Holdings Inc. (IQV) | $30.60B | 11.65 | 13.97 | 20.37 | 21.30 |
| Hologic, Inc. (HOLX) | $16.97B | 17.18 | 16.11 | 18.13 | 14.57 |
| Centene Corporation (CNC) | $31.94B | 5.05 | 8.66 | 22.84 | 17.16 |
Free Cash Flow Valuation
P/FCF Ratio
113.8
FCF Yield
0.88%
Waters Corporation Price/FCF Ratio Formula & Definition
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Waters Corporation Price/FCF Ratio FAQ
- What is the Price/FCF ratio for Waters Corporation (WAT)?
- The Price/FCF ratio for WAT stock is 113.83.
- Is Waters Corporation's Price/FCF ratio high or low?
- Waters Corporation's Price/FCF ratio of 113.83 is 196% above its 5-year average of 38.40, near the high end of its 5-year range (26.75–119.34).
- What is the TTM average Price/FCF ratio for Waters Corporation (WAT)?
- The TTM average Price/FCF ratio for WAT stock is 40.12.
- What is the 3Y average Price/FCF ratio for Waters Corporation (WAT)?
- The 3Y average Price/FCF ratio for WAT stock is 39.39.
- What is the 5Y average Price/FCF ratio for Waters Corporation (WAT)?
- The 5Y average Price/FCF ratio for WAT stock is 38.40.
- What is the 10Y average Price/FCF ratio for Waters Corporation (WAT)?
- The 10Y average Price/FCF ratio for WAT stock is 33.21.
- What is the 15Y average Price/FCF ratio for Waters Corporation (WAT)?
- The 15Y average Price/FCF ratio for WAT stock is 29.69.
- What is the 20Y average Price/FCF ratio for Waters Corporation (WAT)?
- The 20Y average Price/FCF ratio for WAT stock is 27.27.
Waters Corporation Price/FCF Ratio History
| DATE | PRICE/FCF RATIO |
|---|---|
| 2026-06-10 | 113.83 |
| 2026-06-09 | 115.48 |
| 2026-06-08 | 113.05 |
| 2026-06-05 | 113.68 |
| 2026-06-04 | 117.13 |
| 2026-06-03 | 118.16 |
| 2026-06-02 | 115.72 |
| 2026-06-01 | 117.66 |
| 2026-05-29 | 119.34 |
| 2026-05-28 | 114.08 |
| 2026-05-27 | 106.46 |
| 2026-05-26 | 105.36 |
| 2026-05-22 | 106.52 |
| 2026-05-21 | 106.09 |
| 2026-05-20 | 106.20 |
| 2026-05-19 | 103.69 |
| 2026-05-18 | 103.36 |
| 2026-05-15 | 102.43 |
| 2026-05-14 | 103.67 |
| 2026-05-13 | 104.21 |
| 2026-05-12 | 109.58 |
| 2026-05-11 | 38.54 |
| 2026-05-08 | 39.32 |
| 2026-05-07 | 38.80 |
| 2026-05-06 | 38.70 |
| 2026-05-05 | 37.92 |
| 2026-05-04 | 33.42 |
| 2026-05-01 | 34.00 |
| 2026-04-30 | 34.24 |
| 2026-04-29 | 32.34 |
| 2026-04-28 | 33.29 |
| 2026-04-27 | 33.19 |
| 2026-04-24 | 34.31 |
| 2026-04-23 | 34.45 |
| 2026-04-22 | 37.02 |
| 2026-04-21 | 37.11 |
| 2026-04-20 | 37.16 |
| 2026-04-17 | 36.29 |
| 2026-04-16 | 35.32 |
| 2026-04-15 | 36.11 |
| 2026-04-14 | 36.64 |
| 2026-04-13 | 35.95 |
| 2026-04-10 | 35.43 |
| 2026-04-09 | 35.17 |
| 2026-04-08 | 35.26 |
| 2026-04-07 | 34.03 |
| 2026-04-06 | 33.67 |
| 2026-04-02 | 33.68 |
| 2026-04-01 | 33.20 |
| 2026-03-31 | 32.97 |
| 2026-03-30 | 32.48 |
| 2026-03-27 | 32.01 |
| 2026-03-26 | 33.28 |
| 2026-03-25 | 33.47 |
| 2026-03-24 | 33.43 |
| 2026-03-23 | 33.41 |
| 2026-03-20 | 33.10 |
| 2026-03-19 | 33.17 |
| 2026-03-18 | 32.67 |
| 2026-03-17 | 32.88 |
| 2026-03-16 | 32.11 |
| 2026-03-13 | 31.73 |
| 2026-03-12 | 31.37 |
| 2026-03-11 | 32.94 |
| 2026-03-10 | 33.17 |
| 2026-03-09 | 33.84 |
| 2026-03-06 | 33.49 |
| 2026-03-05 | 34.94 |
| 2026-03-04 | 35.32 |
| 2026-03-03 | 34.56 |
| 2026-03-02 | 34.01 |
| 2026-02-27 | 35.36 |
| 2026-02-26 | 35.74 |
| 2026-02-25 | 35.37 |
| 2026-02-24 | 36.13 |
| 2026-02-23 | 36.29 |
| 2026-02-20 | 33.00 |
| 2026-02-19 | 32.54 |
| 2026-02-18 | 32.42 |
| 2026-02-17 | 31.82 |
| 2026-02-13 | 32.01 |
| 2026-02-12 | 31.66 |
| 2026-02-11 | 32.59 |
| 2026-02-10 | 32.37 |
| 2026-02-09 | 32.48 |
| 2026-02-06 | 37.75 |
| 2026-02-05 | 37.31 |
| 2026-02-04 | 38.05 |
| 2026-02-03 | 37.51 |
| 2026-02-02 | 37.55 |
| 2026-01-30 | 36.70 |
| 2026-01-29 | 37.14 |
| 2026-01-28 | 38.12 |
| 2026-01-27 | 38.62 |
| 2026-01-26 | 38.70 |
| 2026-01-23 | 38.84 |
| 2026-01-22 | 39.64 |
| 2026-01-21 | 39.27 |
| 2026-01-20 | 38.00 |
| 2026-01-16 | 38.35 |
| 2026-01-15 | 39.06 |
| 2026-01-14 | 38.93 |
| 2026-01-13 | 39.01 |
| 2026-01-12 | 38.97 |
| 2026-01-09 | 39.28 |
| 2026-01-08 | 39.27 |
| 2026-01-07 | 39.54 |
| 2026-01-06 | 39.65 |
| 2026-01-05 | 39.10 |
| 2026-01-02 | 37.81 |
| 2025-12-31 | 37.60 |
| 2025-12-30 | 38.01 |
| 2025-12-29 | 38.12 |
| 2025-12-26 | 38.22 |
| 2025-12-24 | 38.10 |
| 2025-12-23 | 37.94 |
| 2025-12-22 | 38.03 |
| 2025-12-19 | 37.42 |
| 2025-12-18 | 37.25 |
| 2025-12-17 | 37.33 |
| 2025-12-16 | 37.47 |
| 2025-12-15 | 38.16 |
| 2025-12-12 | 38.15 |
| 2025-12-11 | 38.83 |
| 2025-12-10 | 39.18 |
| 2025-12-09 | 38.23 |
| 2025-12-08 | 38.88 |
| 2025-12-05 | 39.08 |
| 2025-12-04 | 39.24 |
| 2025-12-03 | 39.36 |
| 2025-12-02 | 39.46 |
| 2025-12-01 | 39.38 |
| 2025-11-28 | 39.94 |
| 2025-11-26 | 40.31 |
| 2025-11-25 | 40.84 |
| 2025-11-24 | 39.55 |
| 2025-11-21 | 39.00 |
| 2025-11-20 | 37.48 |
| 2025-11-19 | 37.25 |
| 2025-11-18 | 37.28 |
| 2025-11-17 | 37.42 |
| 2025-11-14 | 37.56 |
| 2025-11-13 | 37.55 |
| 2025-11-12 | 38.35 |
| 2025-11-11 | 38.23 |
| 2025-11-10 | 37.28 |
| 2025-11-07 | 36.80 |
| 2025-11-06 | 36.74 |
| 2025-11-05 | 36.82 |
| 2025-11-04 | 36.37 |
| 2025-11-03 | 33.29 |
| 2025-10-31 | 33.67 |
| 2025-10-30 | 33.03 |
| 2025-10-29 | 33.08 |
| 2025-10-28 | 33.32 |
| 2025-10-27 | 33.88 |
| 2025-10-24 | 34.63 |
| 2025-10-23 | 34.26 |
| 2025-10-22 | 33.58 |
| 2025-10-21 | 33.64 |
| 2025-10-20 | 33.05 |
| 2025-10-17 | 32.23 |
| 2025-10-16 | 32.25 |
| 2025-10-15 | 32.02 |
| 2025-10-14 | 32.09 |
| 2025-10-13 | 32.40 |
| 2025-10-10 | 31.88 |
| 2025-10-09 | 31.83 |
| 2025-10-08 | 31.56 |
| 2025-10-07 | 30.66 |
| 2025-10-06 | 31.56 |
| 2025-10-03 | 31.63 |
| 2025-10-02 | 31.01 |
| 2025-10-01 | 30.80 |
| 2025-09-30 | 28.88 |
| 2025-09-29 | 27.88 |
| 2025-09-26 | 28.10 |
| 2025-09-25 | 27.72 |
| 2025-09-24 | 28.19 |
| 2025-09-23 | 28.82 |
| 2025-09-22 | 29.13 |
| 2025-09-19 | 28.98 |
| 2025-09-18 | 29.51 |
| 2025-09-17 | 29.25 |
| 2025-09-16 | 29.19 |
| 2025-09-15 | 28.80 |
| 2025-09-12 | 28.45 |
| 2025-09-11 | 29.13 |
| 2025-09-10 | 28.22 |
| 2025-09-09 | 28.95 |
| 2025-09-08 | 29.80 |
| 2025-09-05 | 29.50 |
| 2025-09-04 | 28.87 |
| 2025-09-03 | 27.94 |
| 2025-09-02 | 28.56 |
| 2025-08-29 | 29.07 |
| 2025-08-28 | 28.67 |
| 2025-08-27 | 28.38 |
| 2025-08-26 | 28.52 |
| 2025-08-25 | 28.79 |
| 2025-08-22 | 29.11 |
| 2025-08-21 | 27.98 |
| 2025-08-20 | 28.58 |
| 2025-08-19 | 28.68 |
| 2025-08-18 | 27.87 |
| 2025-08-15 | 28.08 |
| 2025-08-14 | 28.27 |
| 2025-08-13 | 28.59 |
| 2025-08-12 | 27.50 |
| 2025-08-11 | 26.90 |
| 2025-08-08 | 27.09 |
| 2025-08-07 | 26.78 |
| 2025-08-06 | 26.75 |
| 2025-08-05 | 27.08 |
| 2025-08-04 | 27.51 |
| 2025-08-01 | 27.99 |
| 2025-07-31 | 27.84 |
| 2025-07-30 | 28.84 |
| 2025-07-29 | 29.24 |
| 2025-07-28 | 29.16 |
| 2025-07-25 | 29.21 |
| 2025-07-24 | 28.78 |
| 2025-07-23 | 28.51 |
| 2025-07-22 | 27.72 |
| 2025-07-21 | 27.16 |
| 2025-07-18 | 27.73 |
| 2025-07-17 | 28.63 |
| 2025-07-16 | 27.92 |
| 2025-07-15 | 27.92 |
| 2025-07-14 | 29.33 |
| 2025-07-11 | 34.03 |
| 2025-07-10 | 34.07 |
| 2025-07-09 | 33.67 |
| 2025-07-08 | 33.54 |
| 2025-07-07 | 33.43 |
| 2025-07-03 | 33.77 |
| 2025-07-02 | 33.93 |
| 2025-07-01 | 34.43 |
| 2025-06-30 | 33.66 |
| 2025-06-27 | 33.98 |
| 2025-06-26 | 34.22 |
| 2025-06-25 | 33.75 |
| 2025-06-24 | 33.44 |
| 2025-06-23 | 33.06 |
| 2025-06-20 | 33.04 |
| 2025-06-18 | 32.72 |
| 2025-06-17 | 32.89 |
| 2025-06-16 | 33.54 |
| 2025-06-13 | 33.01 |
| 2025-06-12 | 33.71 |
| 2025-06-11 | 33.37 |
| 2025-06-10 | 33.73 |
| 2025-06-09 | 33.59 |
| 2025-06-06 | 33.86 |
| 2025-06-05 | 33.40 |
| 2025-06-04 | 34.05 |
| 2025-06-03 | 33.69 |
| 2025-06-02 | 33.14 |
| 2025-05-30 | 33.68 |
| 2025-05-29 | 34.26 |
Showing the most recent 260 of 5,031 data points. The chart above shows the full history.
Related Metrics
About Waters Corporation
Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like chromatography columns and comprehensive post-warranty service plans. The TA segment focuses on designing, producing, selling, and servicing instruments for thermal analysis, rheometry, and calorimetry. Additionally, Waters develops and supplies sophisticated software that integrates with both its own instruments and those from other manufacturers. The company's advanced MS technology plays a crucial role in various applications, such as drug discovery and development (including clinical trial assessments), analyzing proteins involved in disease processes, ensuring nutritional safety, and conducting environmental testing. Its thermal analysis, rheometry, and calorimetry instruments are vital for assessing the suitability and stability of a wide range of materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments support diverse sectors like industrial manufacturing, consumer goods, healthcare products, and life science research. Waters' extensive client base spans the life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors, where its products are instrumental in research and development, quality assurance, and general laboratory operations. Established in 1958, Waters Corporation is headquartered in Milford, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Udit Batra